Alembic Pharma Signs Shareholders' Agreement to Buy 45% Stake in Canadian Pharma Venture

Alembic Pharmaceuticals has signed a shareholders' agreement to invest in a newly incorporated company in Canada, as per an exchange filing dated June 6, 2026.  

The investment will give Alembic a 45% equity stake in 17989377 Canada Inc., while Difgen Holdings LLC will hold another 45%. The remaining 10% stake will be held by other shareholders. 

Venture to Focus on Canadian Market 

The newly formed company has been set up to undertake the development, commercialisation, distribution and marketing of pharmaceutical products in Canada.  

The filing said the venture will serve as a platform dedicated to business activities in the Canadian pharmaceutical market. 

Governance and Ownership Structure 

The board of the Canadian company will include nominee directors representing the shareholders along with an independent director.  

The shareholders' agreement also provides participating investors with customary rights on important business decisions.  

After the investment is completed, the Canadian entity will become an associate company of Alembic Pharmaceuticals. 

Other Disclosures 

The company said the investment is not a related party transaction and confirmed that the joint venture partners are not connected with Alembic's promoter or promoter group. It also stated that no potential conflict of interest is expected to arise from the agreement.  

Since the transaction relates to investment in a newly incorporated company, details regarding issue price and class of shares are not applicable. 

Read More: NIBE Share Price in Focus; Its Unit Receives Lifetime Arms Manufacturing License from DPIIT! 

Alembic Pharmaceuticals Share Price Performance  

As of June 8, 2026, 1:15 pm, Alembic Pharmaceuticals share price was trading at ₹744.00, a 0.76% increase from the previous closing price. 

Conclusion 

The investment will give Alembic Pharmaceuticals a 45% stake in the newly incorporated Canadian company, which is focused on pharmaceutical development and marketing in Canada. The venture will operate as an associate company after the transaction is completed. 

For daily market updates and regular stock market news in Hindi, stay tuned to Angel One's share market news in Hindi. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.   
 
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.